AICDA and neoplasm: Owing to its inter- and intra-tumor heterogeneity inducing capacity, AID/APOBEC family has the potential to affect the pathogenesis and clinical presentation, e.g. prognosis and response to treatment, of lymphomas as well as other malignancies.